Conference abstractPublished 4 Aug 2015
The choice of rhamnetin, sakuranetin and genkwanin as nutraceutical, pharmaceutical and cosmeceutical agents
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Rhamnetin, sakuranetin and genkwanin are uncommon plant secondary metabolites and have been suggested to be potent pharmaceutical agents by some research groups. Evidences were based on the findings conducted on rat models, lung cancer cells, nasopharyngeal carcinoma cells and many in vivo and in vitro experiments. We also conducted several experiments in vitro and found out these compounds were more potent than their original counterparts; quercetin, naringenin and apigenin respectively. While these results sounds promising and worthy of further investigations, we speculate that these compounds warrant further investigation in vivo as potential new therapeutic anti-carcinogenic, anti-melanogenic and anti-angiogenic agents. We want to draw the attention of the nutraceutical, pharmaceutical and cosmeceutical communities.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Biotechnology & Biomaterials
- SubjectBiochemistry & Biotechnology
- SubjectMaterials Science
- BylineArticles whose byline prints “Niranjan Koirala”
- BylineArticles whose byline prints “Sumangala Darsandhari”
- BylineArticles whose byline prints “Hye Jin Jung”
- BylineArticles whose byline prints “Jae Kyung Sohng”